Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mack

Showing results (351-360 of 444) with videos related to

Pageof 45
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancerAmir Goldkorn, Benjamin Ely, David I Quinn, et al.
JAMA Oncology|July 15, 2021
Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical TrialScott N Gettinger, Mary W Redman, Lyudmila Bazhenova, et al.
Clinical Genitourinary Cancer|June 6, 2017
Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421Guru Sonpavde, Gregory R Pond, Melissa Plets, et al.
Journal of the National Cancer Institute|March 24, 2025
In the time of COVID-19: challenges, successes and lessons learned from studies in cancer patientsPhilip C Mack, James M Crawford, Andres Chang, et al.
Nature Neuroscience|March 28, 2017
Purine synthesis promotes maintenance of brain tumor initiating cells in gliomaXiuxing Wang, Kailin Yang, Qi Xie, et al.
JAMA|May 26, 2018
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical TrialEdward M Messing, Catherine M Tangen, Seth P Lerner, et al.
Clinical Lung Cancer|April 4, 2015
Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platformDavid R Gandara, Philip C Mack, Carol Bult, et al.
Acta Neuropathologica|August 15, 2014
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cellsMark Barszczyk, Pawel Buczkowicz, Pedro Castelo-Branco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP StudyPhilip C Mack, Mary W Redman, Hanna Tukachinsky, et al.
The New Phytologist|July 1, 2009
Global patterns of foliar nitrogen isotopes and their relationships with climate, mycorrhizal fungi, foliar nutrient concentrations, and nitrogen availabilityJoseph M Craine, Andrew J Elmore, Marcos P M Aidar, et al.
Pageof 45

Showing results (351-360 of 444) with videos related to

Sort By:
Pageof 45
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancerAmir Goldkorn, Benjamin Ely, David I Quinn, et al.
JAMA Oncology|July 15, 2021
Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical TrialScott N Gettinger, Mary W Redman, Lyudmila Bazhenova, et al.
Clinical Genitourinary Cancer|June 6, 2017
Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421Guru Sonpavde, Gregory R Pond, Melissa Plets, et al.
Journal of the National Cancer Institute|March 24, 2025
In the time of COVID-19: challenges, successes and lessons learned from studies in cancer patientsPhilip C Mack, James M Crawford, Andres Chang, et al.
Nature Neuroscience|March 28, 2017
Purine synthesis promotes maintenance of brain tumor initiating cells in gliomaXiuxing Wang, Kailin Yang, Qi Xie, et al.
JAMA|May 26, 2018
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical TrialEdward M Messing, Catherine M Tangen, Seth P Lerner, et al.
Clinical Lung Cancer|April 4, 2015
Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platformDavid R Gandara, Philip C Mack, Carol Bult, et al.
Acta Neuropathologica|August 15, 2014
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cellsMark Barszczyk, Pawel Buczkowicz, Pedro Castelo-Branco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2025
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP StudyPhilip C Mack, Mary W Redman, Hanna Tukachinsky, et al.
The New Phytologist|July 1, 2009
Global patterns of foliar nitrogen isotopes and their relationships with climate, mycorrhizal fungi, foliar nutrient concentrations, and nitrogen availabilityJoseph M Craine, Andrew J Elmore, Marcos P M Aidar, et al.
Pageof 45